Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer

Integrative Cancer Therapies

Volumn 11, Issue 2, 2012, Pages 83-89

  Bauer, Christina M ^a   Ishak, Miriam B ^a   Johnson, Emilie K ^a   Beebe Dimmer, Jennifer L ^b   Cooney, Kathleen A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

chemoprevention; complementary and alternative medicine; hereditary cancer; prostate cancer; vitamins supplements

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; MAGNESIUM; MULTIVITAMIN; RETINOL; SELENIUM; ZINC;

ADULT; AGE DISTRIBUTION; ALTERNATIVE MEDICINE; ARTICLE; CANCER PREVENTION; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; FAMILY HISTORY; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK FACTOR; SABAL; TEA; VITAMIN SUPPLEMENTATION;

COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MICHIGAN; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; VITAMINS;

EID: 84862019134     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735411413262     Document Type: Article

References (23)

1. Zeegers MP, Schouten LJ, Goldbohm RA, van den Brandt PA. A compendium of familial relative risks of cancer among first degree relatives: a population-based study. Int J Cancer. 2008;123:1664-1673.
2. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al Nutritional Prevention of Cancer Study Group. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003;91:608-612. (Pubitemid 36583728)
3. Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 1995;62(6 suppl):1427S-1430S.
4. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39-51.
5. Bonnar-Pizzorno RM, Littman AJ, Kestin M, White E. Saw palmetto supplement use and prostate cancer risk. Nutr Cancer. 2006;55:21-27. (Pubitemid 44477041)
6. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc. 2004;104:942-950. (Pubitemid 38698291)
7. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337-344. (Pubitemid 34251967)
8. Rock CL. Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr. 2007;85:277S-279S. (Pubitemid 46067648)
9. National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science conference statement: multivitamin/mineral supplements and chronic disease prevention. 2006. http://consensus.nih.gov/2006/multivitaminstatement.pdf. Accessed June 27, 2011.
10. Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst. 2007;99:754-764. (Pubitemid 47073522)
11. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med. 2002;162:1472-1476. (Pubitemid 34747480)
12. Uzzo RG, Brown JG, Horwitz EM, et al. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU Int. 2004;93:955-960. (Pubitemid 38758612)
13. Neuhouser ML, Barnett MJ, Kristal AR, et al. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 2009;18:2202-2206.
14. Schröder FH, Roobol MJ, Boevé ER, et al. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol. 2005;48:922-930. (Pubitemid 41641637)
15. Kranse R, Dagnelie PC, van Kemenade MC, et al. Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study. Int J Cancer. 2005;113:835-840. (Pubitemid 40101267)
16. Health USNIo. Clinical Trials Registry. 2010;http://www.clinicaltrials. gov. Accessed February 1, 2010.
17. Thompson CA. Finasteride may prevent prostate cancer. Am J Health Syst Pharm. 2003;60:1511-1515.
18. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215-224. (Pubitemid 36859473)
19. Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362: 1192-1202.
20. Hall JD, Bissonette EA, Boyd JC, Theodorescu D. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. BJU Int. 2003;91:603-607. (Pubitemid 36583727)
21. Swarup AB, Barrett W, Jazieh AR. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Am J Clin Oncol. 2006;29:468-473. (Pubitemid 44536028)
22. Beebe-Dimmer JL, Wood DP Jr, Gruber SB, et al. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study. Urology. 2004;63:282-287. (Pubitemid 38234419)
23. Nam RK, Fleshner N, Rakovitch E, et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol. 1999;161: 1521-1524. (Pubitemid 29420810)